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USE OF AUTOLOGOUS 
UMBILICAL ARTERY AND 
VEIN FOR VASCULAR 
RECONSTRUCTION IN THE 
NEWBORN 
Autologous umbilical artery and vein were evaluated as vascular conduits in 
newborn lambs. Eight newborn lambs were delivered transabdominaily under sterile 
conditions at term. The umbilical artery and vein were dissected from the cord and 
stored in culture media. On the same day, each lamb underwent bilateral superficial 
femoral artery transection and reconstruction. Nine arteries were reconstructed 
with autologous umbilical vein interposition grafts, five with umbilical artery 
interposition grafts, and two by primary native artery anastomosis. After the birth 
weight of the lambs quadrupled (37 to 45 days), they were killed and all grafts and 
anastomoses were examined grossly and histologically. At the conclusion of the 
study, both native artery anastomoses (2/2) were patent. Five umbilical vein (5/9) 
and two umbilical artery (2/5) autografts were also widely patent. Patent autografts 
retained an intact endothelium supported by a viable media. The nonpatent 
autografts had become atrophic remnants displaying histologic signs of early 
closure. Graft failures are attributed to the extreme vasoactive nature of the 
umbilical vessels. These preliminary results suggest hat umbilical vessels may be 
useful as a vascular autograft if the vasoactive nature of these vessels can be 
overcome during the immediate perioperative period. (J THORAC CARDIOVASC SURG 
1995;109:854-7) 
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V ascular substitutes, uch as polytetrafluoroethyl- ene, Dacron polyester, and treated pericardium, 
play an integral role in the surgical repair of many 
congenital cardiovascular defects. Unfortunately, 
several studies document an increased incidence of 
endocarditis n patients whose repairs involved syn- 
thetic materials, a-3 In addition, nonviable grafting 
materials do not enlarge as the child grows. Subse- 
quent reoperation(s) may become necessary to im- 
prove hemodynamics in the area of the graft as the 
patient grows. 4 Although synthetic and nonviable 
vascular substitutes have enhanced the successful re- 
pair of many congenital cardiovascular defects, the 
optimal grafting material has yet to be described. 
Naturally, the ideal intravascular graft would be 
living, autologous vasculature. An intact endothe- 
lium would provide a nonthrombogenic intravascu- 
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lar surface resistant o bacterial adherence. The 
intima would be supported by a living media and 
adventitia that could grow as the surrounding tissues 
and child grow. 
Current advancements in echocardiographic te h- 
niques now permit the accurate antenatal diagnosis 
of many congenital heart defects necessitating sur- 
gical palliation or repair, s' 6 With this prenatal in- 
sight, we hypothesized that the autologous cord 
vessels, if properly preserved, may provide a more 
suitable material for subsequent vascular recon- 
struction than those currently used. 
Several questions regarding the state of differen- 
tiation and the growth potential of the umbilical 
vasculature remain unanswered. First, is the umbil- 
ical vasculature senescent and doomed to atrophy or 
will this tissue remain viable if autografted into 
physiologically similar milieu? Second, are the cells 
of the umbilical vasculature fully differentiated and 
incapable of growth or does this tissue have further 
growth potential? With these questionsin mind, we 
explored the utility of autologous umbilical artery and 
vein as an arterial substitute in the newbom lamb. 
Materials and methods 
Experimental animals. Four pregnant ewes carrying 
twins were obtained near term. Lambs were delivered 
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Fig. 1. A, Umbilical artery autograft in situ at necropsy. The proximal native vessel is to the right. B, Autograft of A after 
the graft was opened longitudinally. The inner surface of the native artery and autograft are covered by a smooth intimal 
surface. No evidence of stenosis or hyperplasia exists grossly. Note that the midportion of the graft is in spasm and, as a 
consequence, appears narrowed. 
transabdominally under sterile conditions. The autolo- 
gous urnbilical vessels were properly abeled, dissected 
free from the cord, and placed in sterile culture media 
until implantation. In contrast to the human condition, the 
lamb umbilical cord has two veins and two arteries. Once 
these vessels are manipulated, the distinction between 
artery and vein becomes very difficult because of spasm. 
Proper identification was facilitated by labeling the veins 
on the intact cord before transection. 
Eight viable lambs were delivered, yielding sixteen 
superficial femoral arteries for grafting experiments. All 
lambs underwent operation (see Operation) on the deliv- 
ery date and were recovered without complication. Lambs 
received aspirin (20 mg) every day starting the afternoon 
of operation. Once lambs achieved four times their birth 
weight (37 to 45 days), they were killed by intravenous 
injection of thiopental sodium (Pentothal). The umbilical 
autografts and anastomoses were then examined both 
grossly and histologieally. 
All procedures were approved and supervised by the 
Animal Care Department at Oregon Health Sciences 
University in compliance with state and federal regula- 
tions. 
Operation. Under general anesthesia, each lamb had 
both superficial femoral arteries exposed. Animals were 
given heparin (100 units/kg) and arterial anastomoses 
were performed in an end-to-end tapered fashion with a 
running 8-0 nonabsorbable suture. Two arteries under- 
weht simple transection and reanastomosis and the other 
fourteen arteries underwent ransection with umbilical 
vessel interposition grafting. Five umbilical artery and 
nine umbilical vein autografts were placed. All autografts 
were open at the conclusion of the operation except for 
two umbilical artery grafts, which rernained in complete 
vasospasm despite topical papaverine and mechanical 
dilation. 
ttistology. Excised specimens were immediately p aced 
in 10% buffered formalin. Sections were prepared for 
examination with a light microscope after being stained 
with hematoxylin and eosin. Transverse sections through 
the center of each autograft, as weil as longitudinal 
sections through each anastomosis, were examined by a 
pathologist (E.A.). Proper identification of umbilical ar- 
tery versus vein was confirmed by the presence or absence 
of vasa vasorum, respectively, as weil as muscular wall 
thickness and luminal size. 
Results 
The two superficial femoral arteries in which 
simple transection and reanastomosis were per- 
formed were widely patent by gross examination. 
Histologically, significant intimal hyperplasia on 
both the proximal and distal sides of the anastomo- 
sis was evident as a proliferation of the intima on the 
luminal side of the internal elastic lamina. 
Five umbilical artery interposition autografts 
were placed. Two of these failed immediately at 
operation because of extreme vasospasm in the 
autograft. Of the remäining three umbilical artery 
autografts, two were patent at the conclusion of the 
study by gross examination (Fig. 1). The luminal 
diameter of the native vessel enlärged from ap- 
proximately 3 mm to 5 mm between birth and 
necropsy in animals with patent autografts. Histo- 
logically, the patent autografts howed minimal to 
no intimal hyperplasia, and all components of the 
vessel wall remained intact. The occluded umbilical 
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Fig. 2. A, Patent umbilical vein autograft in situ at necropsy. The proximal native artery is to the lefl. B, Vein autograft 
of A after the graft was opened longitudinally. The luminal surface is smooth and shiny without stenosis. This autografl is
supple and pliant without he spasticity encountered in the arterial autografts. 
artery autografts were small cordlike structures in 
situ. The proximal and distal native vessels were 
occluded. Collateral vessels were prominent. Histo- 
logically, the lumina were filled with hyperplastic 
intima and the media appeared atrophic. The intima 
and media were distinguishable with diificulty inas- 
rauch as the internal elastic lamina was obliterated. 
No signs of inflammation were evident in any of the 
specimens. 
Of the nine umbilical vein autografts, only five 
remained patent a  the conclusion of the study. 
Although difficulties with vasospasm were ncoun- 
tered at operation, all gratis were widely patent 
before the skin incisions were closed. At necropsy, 
the patent vein autografts were accompanied by a 
prominent proximal and distal native artery approx- 
imately 5 mm in diameter (Fig. 2). The lumina were 
smooth and without evidence of stenosis. Histolog- 
ically, minimal to no intimal hyperplasia was seen in 
the midportion of the graft. All components of the 
vessel wall were intact and without signs of inflam- 
mation. Focal nonobstructive intimal hyperplasia 
was noted at the suture lines. Scattered areas of 
regional calcification were also noted in the outer 
media and adventitia. The occluded vein autograft 
remnants were small and ditficult o distinguish from 
surrounding scar tissue. The adjacent proximal and 
distal native arteries were small and cordlike. Col- 
lateral vessel formation was pronounced. Histolog- 
ically, a hyperplastic intima and atrophic media 
remained identifiable. The histologic findings were 
similar to those seen in segments of obliterated 
umbilical artery graft. Early recanalization was ap- 
parent with several small blood-filled channels een 
on transverse sections. 
Discussion 
The human extracorporeal umbilical vein is a 
sizable vessel with a luminal diameter of 4 to 6 mm 
and a length of 25 to 140 cm. 7 This vessel is usually 
discarded at birth with the placenta. In cases of 
antenatally diagnosed congenital cardiovascular de- 
fects, we postulated that the autologous umbilical 
vein may be used for the subsequent vascular econ- 
struction rather than the nonliving alternatives cur- 
rently used. A literature search was performed and 
no previous studies describing umbilical vessel au- 
tografts in newborn human beings or animals were 
identified. To our knowledge, this is the first study 
describing the use of autologous umbilical artery 
and vein for vascular econstruction i  the newborn. 
The results herein describe our preliminary find- 
ings in an animal model. Overall, umbilical vessel 
autograft patency was poor, with only seven of 
fourteen vessels patent 37 to 45 days after implan- 
tation. We attribute the graft failures to the extreme 
vasospastic nature of these vessels. Two vessels 
failed immediately as a result of severe spasm. The 
time of closure for the remaining nonpatent vessels 
is unknown; however, the marked collateral vessel 
formation combined with their histologic appear- 
ance suggests that these vessel5 occluded early after 
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operation. In retrospect, daily aspirin therapy (see 
Materials and methods) may have actually promoted 
autograft closure by inhibiting synthesis of vasore- 
laxant prostaglandins within the autograft, s 
A promising feature of this study was the gross 
and histologic appearance of the autografts that 
remained patent. These autografts clearly supported 
the proximal and distal circulation as evidenced by 
the enlargement of the native vessels and lack of 
collateral vessel development (Figs. 1 and 2). A 
single layer of endothelium covered the luminal 
surface; a viable media supported the intima. These 
findings demonstrate hat the autologous umbilical 
vasculature can function as a living arterial substi- 
tute. If the vessel lumen remains patent, the viability 
and integrity of the vessel is preserved. 
Some calcific changes were seen in the outer 
segments of the umbilical vein autografts that re- 
mained patent. As mentioned earlier, umbilical ar- 
tery and vein are distinguished by the presence and 
absence of vasa vasorum, respectively. Therefore 
the calcific changes een in the vein autografts may 
be due to ischemic necrosis and subsequent calcifi- 
cation of the outer portions of the vessel, which do 
not receive an adequate nutrient supply after im- 
plantation. 
The umbilieal vasculature is derived from the 
embryo and, as such, is truly autologous. Therefore 
it is no surprise that histologic evidence of inflam- 
mation or rejection was not observed. Furthermore, 
the umbilical vasculature is not senescent; it has the 
capability of remaining viable when used as a vas- 
cular conduit. More elaborate studies are needed to 
determine whether the umbilical vasculature has 
potential for further growth. 
Obviously, additional research is needed to deter- 
mine the clinical utility of autologous umbilical 
vessels as a practical vascular substitute. Their use as 
a vascular patch or baffling material also remains to 
be explored. 
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